跳至主要内容
临床试验/NL-OMON38739
NL-OMON38739已完成不适用

Central Hemodynamics, Augmentation index and Microcirculation after Phlebotomy - CHAMP study

Academisch Medisch Centrum0 个研究点目标入组 42 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
42

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Without volume replacement:
  • - Patients aged 18-75 years receiving phlebotomy at regular intervals (for example because of hemochromatosis, porphyria and polycythemia vera)
  • - Known to tolerate phlebotomy
  • - Willing to participate
  • - Able to provide informed consent.
  • Patients which are known to tolerate phlebotomy without any adverse events are included in the *no-volume replacement group.* Patients who have experienced adverse events after phlebotomy in the past, and are previously assigned to receive volume replacement by their attending physician, are included in the *volume replacement group.* We aim to include the same amount of patients in each group.

排除标准

  • - Pacemaker or ICD device
  • - Atrial fibrillation
  • - Mechanical heart valve
  • - Congestive heart failure (*NYHA III/IV)
  • - Unable to stand up
  • - Uncontrolled hypertension (BP>180/110 mmHg)

研究者

相似试验